Mitochondrial DNA damage is uncommon in cancer but can promote aggressive behaviour

Anticancer Research

Volumn 33, Issue 9, 2013, Pages 3543-3552

  Maybury, Bernard D ^a  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

Carcinogenesis; DNA repair; Metastasis; Mitochondrial DNA; Review

Indexed keywords

CELL NUCLEUS DNA; CIRCULAR DNA; CRE RECOMBINASE; CYTOCHROME B; CYTOCHROME C OXIDASE; GLUTATHIONE PEROXIDASE; HYPOXIA INDUCIBLE FACTOR 1; MITOCHONDRIAL DNA; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; RIBOSOME RNA; TRANSFER RNA;

ANCHORAGE INDEPENDENT GROWTH; APOPTOSIS; CANCER AGGRESSION; CANCER GROWTH; CARCINOGENESIS; CELL MOTILITY; CELL PROLIFERATION; CELL SURVIVAL; COLORECTAL CARCINOMA; DISEASE ACTIVITY; DNA DAMAGE; EX VIVO STUDY; EXCISION REPAIR; HAPLOTYPE; HETEROPLASMY; HOMOLOGOUS RECOMBINATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; METASTASIS; METASTASIS POTENTIAL; MISMATCH REPAIR; MITOCHONDRIAL DYNAMICS; MITOCHONDRIAL GENOME; MITOCHONDRIAL MEMBRANE POTENTIAL; MUTATION RATE; NEOPLASM; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE K RAS; OXIDATIVE STRESS; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN SUBUNIT; REVIEW; SOMATIC MUTATION; SQUAMOUS CELL CARCINOMA; TUMOR BIOPSY; UPREGULATION;

CARCINOGENESIS; DNA REPAIR; METASTASIS; MITOCHONDRIAL DNA; REVIEW;

DNA DAMAGE; DNA, MITOCHONDRIAL; HUMANS; NEOPLASMS;

EID: 84885014085     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (88)

1. Anderson S, Bankier AT, Barrell BG, de Bruijn MH, Coulson AR, Drouin J, Eperon IC, Nierlich DP, Roe BA, Sanger F, Schreier PH, Smith AJ, Staden R and Young IG: Sequence and organization of the human mitochondrial genome. Nature 290(5806): 457-465, 1981.
2. Warburg O: On respiratory impairment in cancer cells. Science 124(3215): 269-270, 1956.
3. Funes JM, Quintero M, Henderson S, Martinez D, Qureshi U, Westwood C, Clements MO, Bourboulia D, Pedley RB, Moncada S and Boshoff C: Transformation of human mesenchymal stem cells increases their dependency on oxidative phosphorylation for energy production. Proc Natl Acad Sci USA 104(15): 6223-6228, 2007.
4. Canter JA, Kallianpur AR, Parl FF and Millikan RC: Mitochondrial DNA G10398A polymorphism and invasive breast cancer in African-American women. Cancer Res 65(17): 8028-8033, 2005.
5. Darvishi K, Sharma S, Bhat AK, Rai E and Bamezai RN: Mitochondrial DNA G10398A polymorphism imparts maternal haplogroup N a risk for breast and esophageal cancer. Cancer Lett 249(2): 249-255, 2007.
6. Covarrubias D, Bai RK, Wong LJ and Leal SM: Mitochondrial DNA variant interactions modify breast cancer risk. J Hum Genet 53(10): 924-928, 2008.
7. Webb E, Broderick P, Chandler I, Lubbe S, Penegar S, Tomlinson IPM and Houlston RS: Comprehensive analysis of common mitochondrial DNA variants and colorectal cancer risk. Br J Cancer 99(12): 2088-2093, 2008.
8. Petros JA, Baumann AK, Ruiz-Pesini E, Amin MB, Sun CQ, Hall J, Lim S, Issa MM, Flanders WD, Hosseini SH, Marshall FF and Wallace DC: mtDNA mutations increase tumorigenicity in prostate cancer. Proc Natl Acad Sci USA 102(3): 719-724, 2005.
9. Chinnery PF, Samuels DC, Elson J and Turnbull DM: Accumulation of mitochondrial DNA mutations in ageing, cancer, and mitochondrial disease: Is there a common mechanism? Lancet 360(9342): 1323-1325, 2002.
10. Chen JZ, Gokden N, Greene GF, Mukunyadzi P and Kadlubar FF: Extensive somatic mitochondrial mutations in primary prostate cancer using laser capture microdissection. Cancer Res 62(22): 6470-6474, 2002.
11. Kong QP, Yao YG, Sun C, Bandelt HJ, Zhu CL and Zhang YP: Phylogeny of east asian mitochondrial DNA lineages inferred from complete sequences. Am J Hum Genet 73(3): 671-676, 2003.
12. Palanichamy MG, Sun C, Agrawal S, Bandelt HJ, Kong QP, Khan F, Wang CY, Chaudhuri TK, Palla V and Zhang YP: Phylogeny of mitochondrial DNA macrohaplogroup N in india, based on complete sequencing: Implications for the peopling of South Asia. Am J Hum Genet 75(6): 966-978, 2004.
13. Achilli A, Rengo C, Magri C, Battaglia V, Olivieri A, Scozzari R, Cruciani F, Zeviani M, Briem E, Carelli V, Moral P, Dugoujon JM, Roostalu U, Loogvali EL, Kivisild T, Bandelt HJ, Richards M, Villems R, Santachiara- Benerecetti AS, Semino O and Torroni A: The molecular dissection of mtDNA haplogroup H confirms that the franco-cantabrian glacial refuge was a major source for the European gene pool. Am J Hum Genet 75(5): 910-918, 2004.
14. Salas A, Yao Y, Macaulay V, Vega A, Carracedo A and Bandelt H: A critical reassessment of the role of mitochondria in tumorigenesis. PLoS Medicine 2(11): 1158-1166, 2005.
15. Polyak K, Li Y, Zhu H, Lengauer C, Willson JKV, Markowitz SD, Trush MA, Kinzler KW and Vogelstein B: Somatic mutations of the mitochondrial genome in human colorectal tumours. Nat Genet 20(3): 291-293, 1998.
16. Hibi K, Nakayama H, Yamazaki T, Takase T, Taguchi M, Kasai Y, Ito K, Akiyama S and Nakao A: Detection of mitochondrial DNA alterations in primary tumors and corresponding serum of colorectal cancer patients. Int J Cancer 94(3): 429-431, 2001.
17. Jeronimo C, Nomoto S, Caballero OL, Usadel H, Henrique R, Varzim G, Oliveira J, Lopes C, Fliss MS and Sidransky D: Mitochondrial mutations in early-stage prostate cancer and bodily fluids. Oncogene 20(37): 5195-5198, 2001.
18. Nishikawa M, Nishiguchi S, Shiomi S, Tamori A, Koh N, Takeda T, Kubo S, Hirohashi K, Kinoshita H, Sato E and Inoue M: Somatic mutation of mitochondrial DNA in cancerous and noncancerous liver tissue in individuals with hepatocellular carcinoma. Cancer Res 61(5): 1843-1845, 2001.
19. Lee H, Li S, Lin J, Wu C, Yeh D and Wei Y: Somatic mutations in the D-loop and decrease in the copy number of mitochondrial DNA in human hepatocellular carcinoma. Mutat Res 547(1-2): 71-78, 2004.
20. Yin P, Wu C, Lin J, Chi C, Wei Y and Lee H: Somatic mutations of mitochondrial genome in hepatocellular carcinoma. Mitochondrion 10(2): 174-182, 2010.
21. Abnet CC, Huppi K, Carrera A, Armistead D, McKenney K, Hu N, Tang ZZ, Taylor PR and Dawsey SM: Control region mutations and the 'common deletion' are frequent in the mitochondrial DNA of patients with esophageal squamous cell carcinoma. BMC Cancer 4: 30, 2004.
22. Kumimoto H, Yamane Y, Nishimoto Y, Fukami H, Shinoda M, Hatooka S and Ishizaki K: Frequent somatic mutations of mitochondrial DNA in esophageal squamous cell carcinoma. Int J Cancer 108(2): 228-231, 2004.
23. Hibi K, Nakayama H, Yamazaki T, Takase T, Taguchi M, Kasai Y, Ito K, Akiyama S and Nakao A: Mitochondrial DNA alteration in esophageal cancer. Int J Cancer 92(3): 319-321, 2001.
24. Zhou S, Kachhap S, Sun W, Wu G, Chuang A, Poeta L, Grumbine L, Mithani SK, Chatterjee A, Koch W, Westra WH, Maitra A, Glazer C, Carducci M, Sidransky D, McFate T, Verma A and Califano JA: Frequency and phenotypic implications of mitochondrial DNA mutations in human squamous cell cancers of the head and neck. Proc Natl Acad Sci USA 104(18): 7540-7545, 2007.
25. Lee S, Han M, Lee K, Back S, Hwang D, Kim H, Shin J, Suh S, Ryang D, Kim H and Shin M: Frequent occurrence of mitochondrial DNA mutations in Barrett's metaplasia without the presence of dysplasia. PLoS ONE 7(5): e37571, 2012.
26. Shin MG, Kajigaya S, Levin BC and Young NS: Mitochondrial DNA mutations in patients with myelodysplastic syndromes. Blood 101(8): 3118-3125, 2003.
27. Linnartz B, Anglmayer R and Zanssen S: Comprehensive scanning of somatic mitochondrial DNA alterations in acute leukemia developing from myelodysplastic syndromes. Cancer Res 64(6): 1966-1971, 2004.
28. Montanini L, Regna-Gladin C, Eoli M, Albarosa R, Carrara F, Zeviani M, Bruzzone MG, Broggi G, Boiardi A and Finocchiaro G: Instability of mitochondrial DNA and MRI and clinical correlations in malignant gliomas. J Neurooncol 74(1): 87-89, 2005.
29. Kirches E, Krause G, Warich-Kirches M, Weis S, Schneider T, Meyer-Puttlitz B, Mawrin C and Dietzmann K: High frequency of mitochondrial DNA mutations in glioblastoma multiforme identified by direct sequence comparison to blood samples. Int J Cancer 93(4): 534-538, 2001.
30. Seoane M, Mosquera-Miguel A, Gonzalez T, Fraga M, Salas A and Costoya JA: The mitochondrial genome is a 'genetic sanctuary' during the oncogenic process. PLoS ONE 6(8): e23327, 2011.
31. Clayton DA, Doda JN and Friedberg EC: The absence of a pyrimidine dimer repair mechanism in mammalian mitochondria. Proc Natl Acad Sci USA 71(7): 2777-2781, 1974.
32. LeDoux SP, Wilson GL, Beecham EJ, Stevnsner T, Wassermann K and Bohr VA: Repair of mitochondrial DNA after various types of DNA damage in Chinese hamster ovary cells. Carcinogenesis 13(11): 1967-1973, 1992.
33. Driggers WJ, LeDoux SP and Wilson GL: Repair of oxidative damage within the mitochondrial DNA of RINr 38 cells. J Biol Chem 268(29): 22042-22045, 1993.
34. Singer TP and Ramsay RR: Mechanism of the neurotoxicity of MPTP: An update. FEBS Lett 274(1-2): 1-8, 1990.
35. Backer JM, Weinstein IB: Mitochondrial DNA is a major cellular target for a dihydrodiol-epoxide derivative of benzo[a]pyrene. Science 209(4453): 297-299, 1980.
36. Niranjan BG, Bhat NK and Avadhani NG: Preferential attack of mitochondrial DNA by aflatoxin B1 during hepatocarcinogenesis. Science 215(4528): 73-75, 1982.
37. Croteau DL and Bohr VA: Repair of oxidative damage to nuclear and mitochondrial DNA in mammalian cells. J Biol Chem 272(41): 25409-25412, 1997.
38. Mason PA, Matheson EC, Hall AG and Lightowlers RN: Mismatch repair activity in mammalian mitochondria. Nucleic Acids Res 31(3): 1052-1058, 2003.
39. Thyagarajan B, Padua RA and Campbell C: Mammalian mitochondria possess homologous DNA recombination activity. J Biol Chem 271(44): 27536-27543, 1996.
40. Kalifa L, Quintana DF, Schiraldi LK, Phadnis N, Coles GL, Sia RA and Sia EA: Mitochondrial genome maintenance: Roles for nuclear nonhomologous end-joining proteins in Saccharomyces cerevisiae. Genetics 190(3): 951-964, 2012.
41. Coene ED, Hollinshead MS, Waeytens AAT, Schelfhout VRJ, Eechaute WP, Shaw MK, Van Oostveldt PMV and Vaux DJ: Phosphorylated BRCA1 is predominantly located in the nucleus and mitochondria. Mol Biol Cell 16(2): 997-1010, 2005.
42. Coffey G, Lakshmipathy U and Campbell C: Mammalian mitochondrial extracts possess DNA end-binding activity: Nucleic Acids Res 27(16): 3348-3354, 1999.
43. Denver DR, Morris K, Lynch M, Vassilieva LL and Thomas WK: High direct estimate of the mutation rate in the mitochondrial genome of Caenorhabditis elegans. Science 289(5488): 2342-2344, 2000.
44. Denver DR, Morris K, Lynch M and Thomas WK: High mutation rate and predominance of insertions in the Caenorhabditis elegans nuclear genome. Nature 430(7000): 679-682, 2004.
45. Haag-Liautard C, Coffey N, Houle D, Lynch M, Charlesworth B and Keightley PD: Direct estimation of the mitochondrial DNA mutation rate in Drosophila melanogaster. PLoS Biol 6(8): e204, 2008.
46. Rezvani HR, Kim AL, Rossignol R, Ali N, Daly M, Mahfouf W, Bellance N, Taïeb A, De Verneuil H, Mazurier F and Bickers DR: XPC silencing in normal human keratinocytes triggers metabolic alterations that drive the formation of squamous cell carcinomas. J Clin Invest 121(1): 195-211, 2011.
47. Otera H, Ishihara N and Mihara K: New insights into the function and regulation of mitochondrial fission. Biochim Biophys Acta 1833(5): 1256-1268, 2013.
48. Shay JW and Ishii S: Unexpected nonrandom mitochondrial DNA segregation in human cell hybrids. Anticancer Res 10(2 A): 279-284, 1990.
49. Park JS, Sharma LK, Li H, Xiang R, Holstein D, Wu J, Lechleiter J, Naylor SL, Deng JJ, Lu J and Bai Y: A heteroplasmic, not homoplasmic, mitochondrial DNA mutation promotes tumorigenesis via alteration in reactive oxygen species generation and apoptosis. Hum Mol Genet 18(9): 1578-1589, 2009.
50. Sun W, Zhou S, Chang SS, McFate T, Verma A and Califano JA: Mitochondrial mutations contribute to HIF1α accumulation via increased reactive oxygen species and upregulated pyruvate dehydrogenase kinase 2 in head and neck squamous cell carcinoma. Clin Cancer Res 15(2): 476-484, 2009.
51. Jandova J, Shi M, Norman KG, Stricklin GP and Sligh JE: Somatic alterations in mitochondrial DNA produce changes in cell growth and metabolism supporting a tumorigenic phenotype. Biochim Biophys Acta 1822(2): 293-300, 2012.
52. Ishikawa K, Takenaga K, Akimoto M, Koshikawa N, Yamaguchi A, Imanishi H, Nakada K, Honma Y and Hayashi J: ROSgenerating mitochondrial DNA mutations can regulate tumor cell metastasis. Science 320(5876): 661-664, 2008.
53. Woo DK, Green PD, Santos JH, D'Souza AD, Walther Z, Martin WD, Christian BE, Chandel NS and Shadel GS: Mitochondrial genome instability and ROS enhance intestinal tumorigenesis in Apc min/+ mice. Am J Pathol 180(1): 24-31, 2012.
54. Weinberg F, Hamanaka R, Wheaton WW, Weinberg S, Joseph J, Lopez M, Kalyanaraman B, Mutlu GM, Budinger GRS and Chandel NS: Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity. Proc Natl Acad Sci USA 107(19): 8788-8793, 2010.
55. Zielonka J, Kalyanaraman B: "ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis"-a critical commentary. Free Radic Biol Med 45(9): 1217-1219, 2008.
56. Suh Y, Arnold RS, Lassegue B, Shi J, Xu X, Sorescu D, Chung AB, Griendling KK and Lambeth JD: Cell transformation by the superoxide-generating oxidase Mox1. Nature 401(6748): 79-82, 1999.
57. Van Remmen H, Ikeno Y, Hamilton M, Pahlavani M, Wolf N, Thorpe SR, Alderson NL, Baynes JW, Epstein CJ, Huang TT, Nelson J, Strong R and Richardson A: Life-long reduction in MnSOD activity results in increased DNA damage and higher incidence of cancer but does not accelerate aging. Physiol Genomics 16(1): 29-37, 2003.
58. Nekhaeva E, Bodyak ND, Kraytsberg Y, McGrath SB, Van Orsouw NJ, Pluzhnikov A, Wei JY, Vijg J and Khrapko K: Clonally expanded mtDNA point mutations are abundant in individual cells of human tissues. Proc Natl Acad Sci USA 99(8): 5521-5526, 2002.
59. Khrapko K, Bodyak N, Thilly WG, Van Orsouw NJ, Zhang X, Coller HA, Peris TT, Upton M, Vijg J and Wei JY: Cell-by-cell scanning of whole mitochondrial genomes in aged human heart reveals a significant fraction of myocytes with clonally expanded deletions. Nucleic Acids Res 27(11): 2434-2441, 1999.
60. Miller-Messmer M, Kuhn K, Bichara M, le Ret M, Imbault P and Gualberto JM: RecA-dependent DNA repair results in increased heteroplasmy of the Arabidopsis mitochondrial genome. Plant Physiol 159(1): 211-226, 2012.
61. Janicka S, Kühn K, Le Ret M, Bonnard G, Imbault P, Augustyniak H and Gualberto JM: A RAD52-like singlestranded DNA binding protein affects mitochondrial DNA repair by recombination. Plant J 72(3): 423-435, 2012.
62. Simsek D, Furda A, Gao Y, Artus J, Brunet E, Hadjantonakis A, Van Houten B, Shuman S, McKinnon PJ and Jasin M: Crucial role for DNA ligase III in mitochondria but not in Xrcc1-dependent repair. Nature 471(7337): 245-249, 2011.
63. Denko NC: Hypoxia, HIF1 and glucose metabolism in the solid tumour. Nat Rev Cancer 8(9): 705-713, 2008.
64. Yakes FM and Van Houten B: Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc Natl Acad Sci USA 94(2): 514-519, 1997.
65. Wang J, Wilhelmsson H, Graff C, Li H, Oldfors A, Rustin P, Bruning JC, Kahn CR, Clayton DA, Barsh GS, Thoren P and Larsson NG: Dilated cardiomyopathy and atrioventricular conduction blocks induced by heart-specific inactivation of mitochondrial DNA gene expression. Nat Genet 21(1): 133-137, 1999.
66. Zinkewich-Peotti K, Parent M and Morais R: Mitochondrial DNA modulation of the anchorage-independent phenotype of transformed avian cells. Cancer Res 50(20): 6675-6682, 1990.
67. Hayashi J, Takemitsu M and Nonaka I: Recovery of the missing tumorigenicity in mitochondrial DNA-less HeLa cells by introduction of mitochondrial DNA from normal human cells. Somat Cell Mol Genet 18(2): 123-129, 1992.
68. Cavalli LR, Varella-Garcia M and Liang BC: Diminished tumorigenic phenotype after depletion of mitochondrial DNA. Cell Growth Differ 8(11): 1189-1198, 1997.
69. Wang J, Silva JP, Gustafsson CM, Rustin P and Larsson N: Increased in vivo apoptosis in cells lacking mitochondrial DNA gene expression. Proc Natl Acad Sci USA 98(7): 4038-4043, 2001.
70. Kulawiec M, Safina A, Desouki MM, Still I, Matsui S, Bakin A and Singh KK: Tumorigenic transformation of human breast epithelial cells induced by mitochondrial DNA depletion. Cancer Biol Ther 7(11): 1732-1743, 2008.
71. Kujoth CC, Hiona A, Pugh TD, Someya S, Panzer K, Wohlgemuth SE, Hofer T, Seo AY, Sullivan R, Jobling WA, Morrow JD, Van Remmen H, Sedivy JM, Yamasoba T, Tanokura M, Weindruch R, Leeuwenburgh C and Prolla TA: Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science 309(5733): 481-484, 2005.
72. Druzhyna NM, Wilson GL and LeDoux SP: Mitochondrial DNA repair in aging and disease. Mech Ageing Dev 129(7-8): 383-390, 2008.
73. DeHaan C, Habibi-Nazhad B, Yan E, Salloum N, Parliament M and Allalunis-Turner J: Mutation in mitochondrial complex I ND6 subunit is associated with defective response to hypoxia in human glioma cells. Mol Cancer 3: 19, 2004.
74. Porcelli AM, Ghelli A, Ceccarelli C, Lang M, Cenacchi G, Capristo M, Pennisi LF, Morra I, Ciccarelli E, Melcarne A, Bartoletti-Stella A, Salfi N, Tallini G, Martinuzzi A, Carelli V, Attimonelli M, Rugolo M, Romeo G and Gasparre G: The genetic and metabolic signature of oncocytic transformation implicates HIF1A destabilization. Hum Mol Genet 19(6): 1019-1032, 2009.
75. Lott M, Wallace D: Pathological mutations in tRNALeu. MITOMAP http://www.mitomap.org/pub/MITOMAP/mitomap figures/tRNAleu.pdf. Revised 20 June 2013. Last accessed 29 June 2013.
76. dos Santos GC Jr., de Souza Góoes AC, de Vitto H, Moreira CC, Avvad E, Rumjanek FD and de Moura Gallo CV: Genomic instability at the 13q31 locus and somatic mtDNA mutation in the D-loop site correlate with tumor aggressiveness in sporadic Brazilian breast cancer cases. Clinics 67(10): 1181-1190, 2012.
77. Tamori A, Nishiguchi S, Nishikawa M, Kubo S, Koh N, Hirohashi K, Shiomi S and Inoue M: Correlation between clinical characteristics and mitochondrial D-loop DNA mutations in hepatocellular carcinoma. J Gastroenterol 39(11): 1063-1068, 2004.
78. Mambo E, Chatterjee A, Xing M, Tallini G, Haugen BR, Yeung S-J, Sukumar S and Sidransky D: Tumor-specific changes in mtDNA content in human cancer. Int J Cancer 116(6): 920-924, 2005.
79. Nakayama Y, Yamauchi M, Minagawa N, Torigoe T, Izumi H, Kohno K and Yamaguchi K: Clinical significance of mitochondrial transcription factor A expression in patients with colorectal cancer. Oncol Rep 27(5): 1325-1330, 2012.
80. Keefe KA, Schell MJ, Brewer C, McHale M, Brewster W, Chapman JA, Rose GS, McMeeken DS, Lagerberg W, Peng Y, Wilczynski SP, Anton-Culver H, Meyskens FL and Berman ML: A randomized, double blind, phase III trial using oral β-carotene supplementation for women with high-grade cervical intra-epithelial neoplasia. Cancer Epidemiol Biomarkers Prev 10(10): 1029-1035, 2001.
81. Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, Parnes HL, Minasian LM, Gaziano JM, Hartline JA, Parsons JK, Bearden JD III, Crawford ED, Goodman GE, Claudio J, Winquist E, Cook ED, Karp DD, Walther P, Lieber MM, Kristal AR, Darke AK, Arnold KB, Ganz PA, Santella RM, Albanes D, Taylor PR, Probstfield JL, Jagpal TJ, Crowley JJ, Meyskens FL Jr., Baker LH and Coltman CA Jr.: Effect of selenium and vitamin E on risk of prostate cancer and other cancers: The selenium and vitamin E cancer prevention trial (SELECT). JAMA 301(1): 39-51, 2009.
82. Marshall JR, Tangen CM, Sakr WA, Wood DP Jr., Berry DL, Klein EA, Lippman SM, Parnes HL, Alberts DS, Jarrard DF, Lee WR, Gaziano JM, Crawford ED, Ely B, Ray M, Davis W, Minasian LM and Thompson IM Jr.: Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917. Cancer Prev Res 4(11): 1761-1769, 2011.
83. Margalit DN, Kasperzyk JL, Martin NE, Sesso HD, Gaziano JM, Ma J, Stampfer MJ and Mucci LA: Beta-carotene antioxidant use during radiation therapy and prostate cancer outcome in the Physicians' Health Study. Int J Radiat Oncol Biol Phys 83(1): 28-32, 2012.
84. Christofk HR, Vander Heiden MG, Harris MH, Ramanathan A, Gerszten RE, Wei R, Fleming MD, Schreiber SL and Cantley LC: The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 452(7184): 230-233, 2008.
85. Fantin VR, St-Pierre J and Leder P: Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell 9(6): 425-434, 2006.
86. Chandel NS, Maltepe E, Goldwasser E, Mathieu CE, Simon MC and Schumacker PT: Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc Natl Acad Sci USA 95(20): 11715-11720, 1998.
87. Chandel NS, McClintock DS, Feliciano CE, Wood TM, Melendez JA, Rodriguez AM and Schumacker PT: Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1a during hypoxia: A mechanism of O2 sensing. J Biol Chem 275(33): 25130-25138, 2000.
88. Semenza GL: Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene 29(5): 625-634, 2010.